CollPlant Biotechnologies Ltd Directors Remuneration Expense
CollPlant Biotechnologies Ltd (CLGN) reported Directors Remuneration Expense of ILS 1.06 million for the 12-month period ending 2018-12-31, per its 20-F filed 2019-04-01.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:DirectorsRemunerationExpense · last filed 2019-04-01
| Period end | Directors Remuneration Expense 12 month |
|---|---|
| 2018-12-31 | 1.06M ILS 20-F · filed 2019-04-01 |
| 2017-12-31 | 613.00K ILS 20-F · filed 2019-04-01 |
| 2016-12-31 | 1.21M ILS 20-F · filed 2019-04-01 |
| 2015-12-31 | 3.51M ILS 20-F · filed 2018-03-20 |